A review article just published on the state of clinical trials of implantable brain–computer interfaces (doi.org/njn8). Join the conversation. The global landscape ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments. Paradromics, a neurotechnology developer, announced today ...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel ...

The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...

A review published in Advanced Science highlights the evolution of research related to implantable brain-computer interfaces (iBCIs), which decode brain signals that are then translated into commands ...

China’s first clinical trial of a technology that allows signals from the brain to control an external device has shown early signs of success, making it only the second country after the US to reach ...

Cognixion has announced a clinical trial that integrates its non-invasive EEG-based brain–computer interface (BCI) technology with the Apple Vision Pro with no surgery required. The aim of the trial ...

Whether it’s jacking into the Matrix or becoming a Na’avi in Avatar, connecting brains to computers is a science-fiction trope that I never thought I’d see become a reality. But increasingly, BCIs ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Layer 7 Cortical Interface — a high-resolution cortical electrode array for use in recording, monitoring, and stimulating ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

A series of converging advances in bio-implant technology, from brain-spine interfaces to lab-grown spinal tissue, is bringing the long-elusive goal of spinal cord repair closer to clinical reality.